BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 18647984)

  • 1. Cytomegalovirus reactivation in critically ill immunocompetent patients.
    Limaye AP; Kirby KA; Rubenfeld GD; Leisenring WM; Bulger EM; Neff MJ; Gibran NS; Huang ML; Santo Hayes TK; Corey L; Boeckh M
    JAMA; 2008 Jul; 300(4):413-22. PubMed ID: 18647984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus reactivation in a general, nonimmunosuppressed intensive care unit population: incidence, risk factors, associations with organ dysfunction, and inflammatory biomarkers.
    Frantzeskaki FG; Karampi ES; Kottaridi C; Alepaki M; Routsi C; Tzanela M; Vassiliadi DA; Douka E; Tsaousi S; Gennimata V; Ilias I; Nikitas N; Armaganidis A; Karakitsos P; Papaevangelou V; Dimopoulou I
    J Crit Care; 2015 Apr; 30(2):276-81. PubMed ID: 25457114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coreactivation of Human Herpesvirus 6 and Cytomegalovirus Is Associated With Worse Clinical Outcome in Critically Ill Adults.
    Lopez Roa P; Hill JA; Kirby KA; Leisenring WM; Huang ML; Santo TK; Jerome KR; Boeckh M; Limaye AP
    Crit Care Med; 2015 Jul; 43(7):1415-22. PubMed ID: 25821919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomegalovirus reactivation and associated outcome of critically ill patients with severe sepsis.
    Heininger A; Haeberle H; Fischer I; Beck R; Riessen R; Rohde F; Meisner C; Jahn G; Koenigsrainer A; Unertl K; Hamprecht K
    Crit Care; 2011; 15(2):R77. PubMed ID: 21362193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Prospective Monitoring Study of Cytomegalovirus Infection in Non-Immunosuppressed Critical Heart Surgery Patients.
    Lopez Roa P; Perez-Granda MJ; Munoz P; Catalan P; Alonso R; Sanchez-Perez E; Novoa E; Bouza E
    PLoS One; 2015; 10(6):e0129447. PubMed ID: 26070136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Ganciclovir on IL-6 Levels Among Cytomegalovirus-Seropositive Adults With Critical Illness: A Randomized Clinical Trial.
    Limaye AP; Stapleton RD; Peng L; Gunn SR; Kimball LE; Hyzy R; Exline MC; Files DC; Morris PE; Frankel SK; Mikkelsen ME; Hite D; Enfield KB; Steingrub J; O'Brien J; Parsons PE; Cuschieri J; Wunderink RG; Hotchkin DL; Chen YQ; Rubenfeld GD; Boeckh M
    JAMA; 2017 Aug; 318(8):731-740. PubMed ID: 28829877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of cytomegalovirus reactivation on clinical outcomes in immunocompetent critically ill patients: protocol for a systematic review and meta-analysis.
    Lachance P; Chen J; Featherstone R; Sligl W
    Syst Rev; 2016 Jul; 5(1):127. PubMed ID: 27465807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus infection and outcome in immunocompetent patients in the intensive care unit: a systematic review and meta-analysis.
    Li X; Huang Y; Xu Z; Zhang R; Liu X; Li Y; Mao P
    BMC Infect Dis; 2018 Jun; 18(1):289. PubMed ID: 29954328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and risk factors of cytomegalovirus reactivation in critically Ill patients with COVID-19 pneumonia.
    Tassaneeyasin T; Sungkanuparph S; Srichatrapimuk S; Charoensri A; Thammavaranucupt K; Jayanama K; Kirdlarp S
    PLoS One; 2024; 19(5):e0303995. PubMed ID: 38771836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-γ production by CMV-specific CD8+ T lymphocytes provides protection against cytomegalovirus reactivation in critically ill patients.
    Castón JJ; Cantisán S; González-Gasca F; Páez-Vega A; Abdel-Hadi H; Illescas S; Alonso G; Torre-Cisneros J
    Intensive Care Med; 2016 Jan; 42(1):46-53. PubMed ID: 26537489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomegalovirus reactivation in immunocompetent mechanical ventilation patients: a prospective observational study.
    Zhang Z; Liu X; Sang L; Chen S; Wu Z; Zhang J; Sun Y; Huang Y; Xu Y; He W; Li Y; Liu X
    BMC Infect Dis; 2021 Sep; 21(1):1026. PubMed ID: 34592936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus and Epstein-Barr virus reactivation in the intensive care unit.
    Coşkun O; Yazici E; Şahiner F; Karakaş A; Kiliç S; Tekin M; Artuk C; Yamanel L; Beşirbellioğlu BA
    Med Klin Intensivmed Notfmed; 2017 Apr; 112(3):239-245. PubMed ID: 27435067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality.
    Gatto I; Biagioni E; Coloretti I; Farinelli C; Avoni C; Caciagli V; Busani S; Sarti M; Pecorari M; Gennari W; Guaraldi G; Franceschini E; Meschiari M; Mussini C; Tonelli R; Clini E; Cossarizza A; Girardis M;
    Intensive Care Med; 2022 Jun; 48(6):706-713. PubMed ID: 35583676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between Pulmonary Aspergillosis and
    Caciagli V; Coloretti I; Talamonti M; Farinelli C; Gatto I; Biagioni E; Sarti M; Franceschini E; Meschiari M; Mussini C; Tonelli R; Clini E; Girardis M; Busani S; Modena Covid-Working Group
    Viruses; 2023 Nov; 15(11):. PubMed ID: 38005936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors for Cytomegalovirus Reactivation and Association With Outcomes in Critically Ill Adults With Sepsis: A Pooled Analysis of Prospective Studies.
    Imlay H; Dasgupta S; Boeckh M; Stapleton RD; Rubenfeld GD; Chen Y; Limaye AP
    J Infect Dis; 2021 Jun; 223(12):2108-2112. PubMed ID: 33159200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virological and immunological features of active cytomegalovirus infection in nonimmunosuppressed patients in a surgical and trauma intensive care unit.
    Chilet M; Aguilar G; Benet I; Belda J; Tormo N; Carbonell JA; Clari MA; Costa E; Navarro D
    J Med Virol; 2010 Aug; 82(8):1384-91. PubMed ID: 20572085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactivation of Latent Cytomegalovirus Infection after Major Surgery: Risk Factors and Outcomes.
    Gardiner BJ; Herrick KW; Bailey RC; Chow JK; Snydman DR
    Surg Infect (Larchmt); 2019 Jul; 20(5):416-423. PubMed ID: 30912706
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of cytomegalovirus reactivation on the time course of systemic host response biomarkers in previously immunocompetent critically ill patients with sepsis: a matched cohort study.
    van de Groep K; Nierkens S; Cremer OL; Peelen LM; Klein Klouwenberg PMC; Schultz MJ; Hack CE; van der Poll T; Bonten MJM; Ong DSY;
    Crit Care; 2018 Dec; 22(1):348. PubMed ID: 30563551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus infection in critically ill patients: a systematic review.
    Osawa R; Singh N
    Crit Care; 2009; 13(3):R68. PubMed ID: 19442306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CMV in critically ill patients: pathogen or bystander?
    Limaye AP; Boeckh M
    Rev Med Virol; 2010 Nov; 20(6):372-9. PubMed ID: 20931610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.